Clinical Data

Otsuka's kidney disease drug halves UPCR levels in ph. 3 study

Otsuka has shared data behind its kidney disease drug’s win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio levels.

James Waldron Jun 6, 2025 6:26am

An artists depiction of DNA molecules made up of tiny particles

RegenXBio links DMD gene therapy to improved outcomes

Jun 5, 2025 8:52am

Corcept unveils promising survival data from phase 2 ALS fail

Jun 5, 2025 8:21am

Cartoon of businessmen standing around a broken target

Vigil's rare brain disease drug flunks phase 2 study

Jun 4, 2025 9:45am

Ascletis prepares for China regulators after acne pill ph. 3 win

Jun 4, 2025 5:08am

Guardant360-guided breast cancer therapy swaps boost survival

Jun 3, 2025 10:00am